STOCK TITAN

TOI (NASDAQ: TOI) notice covers planned Rule 144 sale of 13,333 shares

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

TOI has a shareholder planning to sell 13,333 shares of common stock under Rule 144.

The shares were acquired as restricted stock from the issuer on 11/21/2025 and are planned to be sold around 12/15/2025 through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $50,290.74. The issuer had 98,381,340 shares of common stock outstanding.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

The Oncology Institute Inc

NASDAQ:TOI

TOI Rankings

TOI Latest News

TOI Latest SEC Filings

TOI Stock Data

370.90M
89.19M
8.88%
40.72%
6.24%
Medical Care Facilities
Services-offices & Clinics of Doctors of Medicine
Link
United States
CERRITOS